International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management

Area of Science:

• Gerontology
• Muscle Physiology
• Clinical Practice Guidelines

Background:

• Sarcopenia, characterized by age-associated skeletal muscle mass and function decline, affects 6-22% of older adults.
• The International Conference on Sarcopenia and Frailty Research (ICSFR) established a task force to create clinical practice guidelines.

Purpose of the Study:

• To develop evidence-based clinical practice guidelines for the screening, diagnosis, and management of sarcopenia.
• To synthesize the best available evidence and expert consensus on sarcopenia management.

Main Methods:

• Guidelines were developed using systematic reviews and consensus statements from international working groups.
• Eight key topics were addressed: definition, screening/diagnosis, physical activity, protein, vitamin D, hormone therapy, medications, and research.
• Recommendations were graded using the GRADE approach (strong or conditional) after evaluating evidence quality, benefit-harm balance, patient values, and cost-effectiveness.

Main Results:

• A conditional recommendation supports using international tools (EWGSOP, FNIH) for sarcopenia diagnosis and rapid screening via gait speed or SARC-F.
• Resistance-based physical activity is strongly recommended for sarcopenia treatment.
• Protein supplementation or a protein-rich diet is conditionally recommended; Vitamin D and anabolic hormones are not recommended due to insufficient evidence.

Conclusions:

• The guidelines provide a framework for consistent sarcopenia screening, diagnosis, and management.
• Resistance exercise and adequate protein intake are key evidence-based interventions.
• Further research is needed to strengthen recommendations for other treatment modalities.